Announced Thu, 2 Jul · 21:46 IST
NCLT shareholders approve Dr Agarwal's Eye Hospital amalgamation scheme
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹5035.00
prior close
₹5035.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+2.5+1.3—-0.7-0.7-2.3-0.3-3.4-0.2-0.3———
Up moveDown movePending
AI summary
NCLT convened meeting on July 2, 2026, where equity shareholders of Dr Agarwal's Eye Hospital approved the Scheme of Amalgamation with Dr Agarwal's Health Care Limited. Of about 44.49 lakh votes cast, 89.86 percent (around 39.98 lakh) voted in favor and 10.14 percent (around 4.51 lakh) voted against. Promoters voted nearly 100 percent in favor. The scheme still needs NCLT sanction and other regulatory clearances before becoming effective.
Likely market impact
Amalgamation clears shareholder hurdle; needs NCLT sanction and other approvals before taking effect, streamlining the group structure.